Your browser doesn't support javascript.
loading
Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning mode
Zuppo Laper, Isabella; Camacho-Hubner, Cecilia; Vansan Ferreira, Rafaela; Leite Bertoli de Souza, Claudenice; Simões, Marcus Vinicius; Fernandes, Fabio; de Barros Correia, Edileide; de Jesus Lopes de Abreu, Ariane; Silva Julian, Guilherme.
Affiliation
  • Zuppo Laper, Isabella; IQVIA Brazil. São Paulo. BR
  • Camacho-Hubner, Cecilia; Pfizer Global. New York City. US
  • Vansan Ferreira, Rafaela; IQVIA Brazil. São Paulo. US
  • Leite Bertoli de Souza, Claudenice; Pfizer Brazil. São Paulo. BR
  • Simões, Marcus Vinicius; Medical School of Ribeirão Preto. University of São Paulo. São Paulo. BR
  • Fernandes, Fabio; Heart Institute. University of São Paulo. São Paulo. BR
  • de Barros Correia, Edileide; Instituto Dante Pazzanese de Cardiologia. São Paulo. BR
  • de Jesus Lopes de Abreu, Ariane; IQVIA Brazil. São Paulo. BR
  • Silva Julian, Guilherme; Pfizer Brazil. São Paulo. BR
PLos ONE ; 19(2): e0278738, fev.2024. ilus, tab
Article in English | CONASS, Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1531135
Responsible library: BR79.1
ABSTRACT

OBJECTIVES:

To identify and describe the profile of potential transthyretin cardiac amyloidosis (ATTR-CM) cases in the Brazilian public health system (SUS), using a predictive machine learning (ML) model.

METHODS:

This was a retrospective descriptive database study that aimed to estimate the frequency of potential ATTR-CM cases in the Brazilian public health system using a supervised ML model, from January 2015 to December 2021. To build the model, a list of ICD-10 codes and procedures potentially related with ATTR-CM was created based on literature review and validated by experts.

RESULTS:

From 2015 to 2021, the ML model classified 262 hereditary ATTR-CM (hATTR-CM) and 1,581 wild-type ATTR-CM (wtATTR-CM) potential cases. Overall, the median age of hATTR-CM and wtATTR-CM patients was 66.8 and 59.9 years, respectively. The ICD-10 codes most presented as hATTR-CM and wtATTR-CM were related to heart failure and arrythmias. Regarding the therapeutic itinerary, 13% and 5% of hATTR-CM and wtATTR-CM received treatment with tafamidis meglumine, respectively, while 0% and 29% of hATTR-CM and wtATTR-CM were referred to heart transplant.

CONCLUSION:

Our findings may be useful to support the development of health guidelines and policies to improve diagnosis, treatment, and to cover unmet medical needs of patients with ATTR-CM in Brazil.
Subject(s)

Full text: Available Collection: National databases / Brazil Database: CONASS / Sec. Est. Saúde SP / SESSP-IDPCPROD Main subject: Amyloid Neuropathies / Cardiomyopathies Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: PLos ONE Year: 2024 Document type: Article Institution/Affiliation country: Heart Institute/BR / IQVIA Brazil/BR / IQVIA Brazil/US / Instituto Dante Pazzanese de Cardiologia/BR / Medical School of Ribeirão Preto/BR / Pfizer Brazil/BR / Pfizer Global/US

Full text: Available Collection: National databases / Brazil Database: CONASS / Sec. Est. Saúde SP / SESSP-IDPCPROD Main subject: Amyloid Neuropathies / Cardiomyopathies Limits: Humans Country/Region as subject: South America / Brazil Language: English Journal: PLos ONE Year: 2024 Document type: Article Institution/Affiliation country: Heart Institute/BR / IQVIA Brazil/BR / IQVIA Brazil/US / Instituto Dante Pazzanese de Cardiologia/BR / Medical School of Ribeirão Preto/BR / Pfizer Brazil/BR / Pfizer Global/US
...